Biomechanical Effects of Two Forms of PGF2α on Ex-vivo Rabbit Cornea

References

• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–67. doi:10.1136/bjo.2005.081224.
   PubMed Web of Science ®Google Scholar
• Ogden RW. Non-linear elastic deformations. Mineola (New York): Dover Publications, Inc; 1997.
   Google Scholar
• INVESTIGATORS. TA. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS investigators. Am J Ophthalmol. 2000;130:429–40.
   PubMed Web of Science ®Google Scholar
• Camras CB. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group. Ophthalmology. 1996;103(1):138–47. doi:10.1016/S0161-6420(96)30749-5.
   PubMed Web of Science ®Google Scholar
• Lindsey JD, Kashiwagi K, Boyle D, Kashiwagi F, Firestein GS, Weinreb RN. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res. 1996;15(8):869–75. doi:10.3109/02713689609017628.
   PubMed Web of Science ®Google Scholar
• Schachtschabel U, Lindsey JD, Weinreb RN. The mechanism of action of prostaglandins on uveoscleral outflow. Curr Opin Ophthalmol. 2000;11(2):112–15. doi:10.1097/00055735-200004000-00008.
   PubMedGoogle Scholar
• Weinreb RN, Lindsey JD, Marchenko G, Marchenko N, Angert M, Strongin A. Prostaglandin FP agonists alter metalloproteinase gene expression in sclera. Invest Ophthalmol Vis Sci. 2004;45(12):4368–77. doi:10.1167/iovs.04-0413.
   PubMed Web of Science ®Google Scholar
• Sagara T, Gaton DD, Lindsey JD, Gabelt BT, Kaufman PL, Weinreb RN. Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch Ophthalmol. 1999;117(6):794–801. doi:10.1001/archopht.117.6.794.
   PubMedGoogle Scholar
• Tamm E, Lutjen-Drecoll E, Rohen JW. Age-related changes of the ciliary muscle in comparison with changes induced by treatment with prostaglandin F2 alpha. An ultrastructural study in rhesus and cynomolgus monkeys. Mech Ageing Dev. 1990;51(2):101–20. doi:10.1016/0047-6374(90)90093-U.
   PubMed Web of Science ®Google Scholar
• Lee PY, Podos SM, Severin C. Effect of prostaglandin F2 alpha on aqueous humor dynamics of rabbit, cat, and monkey. Invest Ophthalmol Vis Sci. 1984;25:1087–93.
   PubMed Web of Science ®Google Scholar
• Gabelt BT, Kaufman PL. Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res. 1989;49(3):389–402. doi:10.1016/0014-4835(89)90049-3.
   PubMed Web of Science ®Google Scholar
• Schlote T, Tzamalis A, Kynigopoulos M. Central corneal thickness during treatment with travoprost 0.004% in glaucoma patients. J Ocul Pharmacol Ther. 2009;25(5):459–62. doi:10.1089/jop.2009.0007.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Shen X, Yu J, Tan H, Cheng Y. The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness. Cornea. 2011;30(8):861–64. doi:10.1097/ICO.0b013e3182000c27.
   PubMed Web of Science ®Google Scholar
• Panos GD, Konstantinidis A, Mendrinos E, Kozobolis V, Perente I, Gatzioufas Z. Effect of tafluprost 0.0015% on central corneal thickness in patients with primary open-angle glaucoma. Curr Eye Res. 2013;38(9):977–82. doi:10.3109/02713683.2013.801495.
   PubMed Web of Science ®Google Scholar
• Bao F, Deng M, Wang Q, Huang J, Yang J, Whitford C, Geraghty B, Yu A, Elsheikh A. Evaluation of the relationship of corneal biomechanical metrics with physical intraocular pressure and central corneal thickness in ex vivo rabbit eye globes. Exp Eye Res. 2015;137:11–17. doi:10.1016/j.exer.2015.05.018.
   PubMed Web of Science ®Google Scholar
• Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci. 2005;46(12):4594–99. doi:10.1167/iovs.05-0776.
   PubMed Web of Science ®Google Scholar
• Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci. 2005;46(7):2444–50. doi:10.1167/iovs.04-1331.
   PubMed Web of Science ®Google Scholar
• Ni S, Yu J, Bao F, Li J, Elsheikh A, Wang Q. Effect of glucose on the stress-strain behavior of ex-vivo rabbit cornea. Exp Eye Res. 2011;92(5):353–60. doi:10.1016/j.exer.2011.02.005.
   PubMed Web of Science ®Google Scholar
• Bao F, Deng M, Zheng X, Li L, Zhao Y, Cao S, Yu AY, Wang Q, Huang J, Elsheikh A. Effects of diabetes mellitus on biomechanical properties of the rabbit cornea. Exp Eye Res. 2017;161:82–88. doi:10.1016/j.exer.2017.05.015.
   PubMed Web of Science ®Google Scholar
• Bao F, Zheng Y, Liu C, Zheng X, Zhao Y, Wang Y, Li L, Wang Q, Chen S, Elsheikh A. Changes in corneal biomechanical properties with different corneal cross-linking irradiances. J Refract Surg. 2018;34(1):51–58. doi:10.3928/1081597X-20171025-01.
   PubMed Web of Science ®Google Scholar
• Yu JG, Bao FJ, Joda A, Fu XA, Zhou S, Wang J, Hu XL, Wang QM, Elsheikh A. Influence of glucocorticosteroids on the biomechanical properties of in-vivo rabbit cornea. J Mech Behav Biomed Mater. 2014;29:350–59. doi:10.1016/j.jmbbm.2013.08.015.
   PubMed Web of Science ®Google Scholar
• Zheng X, Bao F, Geraghty B, Huang J, Yu A, Wang Q. High intercorneal symmetry in corneal biomechanical metrics. Eye Vision. 2016;3:7. doi:10.1186/s40662-016-0037-7.
   Web of Science ®Google Scholar
• Mulhern MG, Condon PI, O’Keefe M. Myopic and hyperopic laser in situ keratomileusis retreatments: indications, techniques, limitations, and results. J Cataract Refract Surg. 2001;27(8):1278–87. doi:10.1016/S0886-3350(01)00981-6.
   PubMed Web of Science ®Google Scholar
• Grupcheva CN, Malik TY, Craig JP, McGhee CN. In vivo confocal microscopy of corneal epithelial ingrowth through a laser in situ keratomileusis flap buttonhole. J Cataract Refract Surg. 2001;27(8):1318–22. doi:10.1016/S0886-3350(01)00753-2.
   PubMed Web of Science ®Google Scholar
• Dhaliwal DK, Romanowski EG, Yates KA, Hu D, Mah FS, Fish DN, Gordon YJ. Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis. J Cataract Refract Surg. 2001;27(8):1288–93. doi:10.1016/S0886-3350(01)00804-5.
   PubMed Web of Science ®Google Scholar
• Wollensak G, Wilsch M, Spoerl E, Seiler T. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA. Cornea. 2004;23(5):503–07. doi:10.1097/01.ico.0000105827.85025.7f.
   PubMed Web of Science ®Google Scholar
• Al-Jazzaf AM, DeSantis L, Netland PA. Travoprost: a potent ocular hypotensive agent. Drugs Today (Barc). 2003;39(1):61–74. doi:10.1358/dot.2003.39.1.799432.
   PubMed Web of Science ®Google Scholar
• Stewart WC, Kolker AE, Stewart JA, Leech J, Jackson AL. Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost. Am J Ophthalmol. 2003;135(3):314–20. doi:10.1016/S0002-9394(02)01980-3.
   PubMed Web of Science ®Google Scholar
• Day DG, Sharpe ED, Atkinson MJ, Stewart JA, Stewart WC. The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye (Lond). 2006;20(5):583–90. doi:10.1038/sj.eye.6701932.
   PubMed Web of Science ®Google Scholar
• Huang P, Zhong Z, Wu L, Liu W. Increased iridial pigmentation in Chinese eyes after use of travoprost 0.004%. J Glaucoma. 2009;18(2):153–56. doi:10.1097/IJG.0b013e31817d2372.
   PubMed Web of Science ®Google Scholar
• Yang HK, Park KH, Kim TW, Kim DM. Deepening of eyelid superior sulcus during topical travoprost treatment. Jpn J Ophthalmol. 2009;53(2):176–79. doi:10.1007/s10384-008-0623-x.
   PubMed Web of Science ®Google Scholar
• Kahook MY, Ammar DA. In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cells. J Ocul Pharmacol Ther. 2010;26(3):259–63. doi:10.1089/jop.2010.0003.
   PubMed Web of Science ®Google Scholar
• Woodward DF, Regan JW, Lake S, Ocklind A. The molecular biology and ocular distribution of prostanoid receptors. Surv Ophthalmol. 1997;41(Suppl 2):S15–21. doi:10.1016/S0039-6257(97)80003-3.
   PubMed Web of Science ®Google Scholar
• Ishida N, Odani-Kawabata N, Shimazaki A, Hara H. Prostanoids in the therapy of glaucoma. Cardiovasc Drug Rev. 2006;24(1):1–10. doi:10.1111/j.1527-3466.2006.00001.x.
   PubMed Web of Science ®Google Scholar
• Ooi YH, Oh DJ, Rhee DJ. Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells. Invest Ophthalmol Vis Sci. 2009;50(11):5259–65. doi:10.1167/iovs.08-3356.
   PubMed Web of Science ®Google Scholar
• Yamada H, Yoneda M, Gosho M, Kato T, Zako M. Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases. BMC Ophthalmol. 2016;16:26. doi:10.1186/s12886-016-0202-8.
   PubMed Web of Science ®Google Scholar
• Takagi Y, Santo K, Hashimoto M, Fukuchi T. Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review. Clin Ophthalmol. 2018;12:1837–44. doi:10.2147/OPTH.S166657.
   PubMed Web of Science ®Google Scholar
• Viestenz A, Martus P, Schlotzer-Schrehardt U, Langenbucher A, Mardin CY. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness – a cross-sectional study on 403 eyes]. Klin Monbl Augenheilkd. 2004;221(9):753–56. doi:10.1055/s-2004-81361.
   PubMed Web of Science ®Google Scholar
• Bergonzi C, Giani A, Blini M, Marchi S, Luccarelli S, Staurenghi G. Evaluation of prostaglandin analogue effects on corneal keratocyte density using scanning laser confocal microscopy. J Glaucoma. 2010;19(9):617–21. doi:10.1097/IJG.0b013e3181ca7c7a.
   PubMed Web of Science ®Google Scholar
• Tsikripis P, Papaconstantinou D, Koutsandrea C, Apostolopoulos M, Georgalas I. The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes. Drug Des Devel Ther. 2013;7:1149–56. doi:10.2147/DDDT.S50622.
   PubMed Web of Science ®Google Scholar
• Agarwal DR, Ehrlich JR, Shimmyo M, Radcliffe NM. The relationship between corneal hysteresis and the magnitude of intraocular pressure reduction with topical prostaglandin therapy. Br J Ophthalmol. 2012;96(2):254–57. doi:10.1136/bjo.2010.196899.
   PubMed Web of Science ®Google Scholar
• Lazcano-Gomez G, Ancona-Lezama D, Gil-Carrasco F, Jimenez-Roman J. Effects of topical travoprost 0.004% on intraocular pressure and corneal biomechanical properties in an animal model. Digital J Ophthalmol. 2016;22:1–5.
   PubMedGoogle Scholar
• Detry-Morel M, Jamart J, Pourjavan S. Evaluation of corneal biomechanical properties with the reichert ocular response analyzer. Eur J Ophthalmol. 2011;21(2):138–48. doi:10.5301/EJO.2010.2150.
   PubMed Web of Science ®Google Scholar
• Meda R, Wang Q, Paoloni D, Harasymowycz P, Brunette I. The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma. Br J Ophthalmol. 2017;101(2):120–25. doi:10.1136/bjophthalmol-2016-308432.
   PubMed Web of Science ®Google Scholar
• Wu N, Chen Y, Yu X, Li M, Wen W, Sun X. Changes in corneal biomechanical properties after long-term topical prostaglandin therapy. PLoS One. 2016;11(5):e0155527. doi:10.1371/journal.pone.0155527.
   PubMed Web of Science ®Google Scholar
• Kotecha A, Elsheikh A, Roberts CR, Zhu H, Garway-Heath DF. Corneal thickness- and age-related biomechanical properties of the cornea measured with the ocular response analyzer. Invest Ophthalmol Vis Sci. 2006;47(12):5337–47. doi:10.1167/iovs.06-0557.
   PubMed Web of Science ®Google Scholar
• Chang PY, Chang SW, Wang JY. Assessment of corneal biomechanical properties and intraocular pressure with the ocular response analyzer in childhood myopia. Br J Ophthalmol. 2010;94(7):877–81. doi:10.1136/bjo.2009.158568.
   PubMed Web of Science ®Google Scholar
• Sullivan-Mee M, Billingsley SC, Patel AD, Halverson KD, Alldredge BR, Qualls C. Ocular response analyzer in subjects with and without glaucoma. Optometry Vision Sci. 2008;85(6):463–70. doi:10.1097/OPX.0b013e3181784673.
   PubMed Web of Science ®Google Scholar
• Tas M, Oner V, Ozkaya E, Durmus M. Evaluation of corneal biomechanical properties in patients with rheumatoid arthritis: a study by ocular response analyzer. Ocul Immunol Inflamm. 2014;22(3):224–27. doi:10.3109/09273948.2013.841957.
   PubMed Web of Science ®Google Scholar
• Hoeltzel DA, Altman P, Buzard K, Choe K. Strip extensiometry for comparison of the mechanical response of bovine, rabbit, and human corneas. J Biomech Eng. 1992;114(2):202–15. doi:10.1115/1.2891373.
   PubMed Web of Science ®Google Scholar
• Elsheikh A, Anderson K. Comparative study of corneal strip extensometry and inflation tests. J R Soc Interface. 2005;2(3):177–85. doi:10.1098/rsif.2005.0034.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yanai R, Lu Y, Hirano S, Sagara T, Nishida T. Effects of antiglaucoma drugs on collagen gel contraction mediated by human corneal fibroblasts. J Glaucoma. 2006;15(3):255–59. doi:10.1097/01.ijg.0000212210.33265.24.
   PubMed Web of Science ®Google Scholar
• Wu KY, Wang HZ, Hong SJ. Effect of latanoprost on cultured porcine corneal stromal cells. Curr Eye Res. 2005;30(10):871–79. doi:10.1080/02713680591006237.
   PubMed Web of Science ®Google Scholar
• Maruyama Y, Mori K, Ikeda Y, Ueno M, Kinoshita S. Effects of long-term topical prostaglandin therapy on central corneal thickness. J Ocul Pharmacol Ther. 2014;30(5):440–44. doi:10.1089/jop.2013.0196.
   PubMed Web of Science ®Google Scholar
• Liu J, Roberts CJ. Influence of corneal biomechanical properties on intraocular pressure measurement: quantitative analysis. J Cataract Refract Surg. 2005;31(1):146–55. doi:10.1016/j.jcrs.2004.09.031.
   PubMed Web of Science ®Google Scholar
• Redbrake C, Salla S, Frantz A, Reim M. [Energy metabolism of the human cornea in various culture systems]. Klin Monbl Augenheilkd. 1997;210(4):213–18. doi:10.1055/s-2008-1035044.
   PubMed Web of Science ®Google Scholar
• Sjoquist B, Basu S, Byding P, Bergh K, Stjernschantz J. The pharmacokinetics of a new antiglaucoma drug, latanoprost, in the rabbit. Drug Metab Dispos. 1998;26:745–54.
   PubMed Web of Science ®Google Scholar
• Pellinen P, Huhtala A, Tolonen A, Lokkila J, Maenpaa J, Uusitalo H. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo. Curr Eye Res. 2012;37(2):145–54. doi:10.3109/02713683.2011.626909.
   PubMed Web of Science ®Google Scholar